Upload
md-specialclass
View
65
Download
4
Tags:
Embed Size (px)
DESCRIPTION
Citation preview
Antianginal DrugsAntianginal Drugs
Claro M. Isidro M.D.
Definition of termsDefinition of terms
Angina Pectoris – is the principal symptoms of patient with ischemic heart disease.
Manifested by sudden, severe, pressing substernal pain that often radiates to the left shoulder and along the flexor surface of the left arm.
Usually precipitated by exercise, excitement or a heavy meal.
Types of AnginaTypes of Angina
Typical Angina ( Classical Angina ) pain is commonly induced by exercise,
excitement or a heavy meal secondary to advanced atherosclerosis of
the coronary vessels associated with ST-segment depression on
ECG
Variant Angina ( Prinzmetal Angina) pain is induced while at rest associated with ST-segment elevation on
ECG secondary to vasospasm of the coronary
vesselsUnstable angina may involve coronary spasm and may also
have the component of atherosclerosis the duration of manifestation is longer than
the first two and has the manifestation of Myocardial infarction
* Myocardial ischemia which produces angina results from imbalances in myocardial oxygen supply & demand relationship such as decreased oxygen supply and/or increased oxygen demand.
Etiology 1. Decrease oxygen supply2. Increase demand for oxygen
Determinant of Myocardial Oxygen Supply1. Coronary blood flow
Determined by: perfusion pressure duration of diastole coronary bed resistance
2. Arterio-venous oxygen difference
Determinant of Myocardial Oxygen demand Major Determinants1. Wall stress
intraventricular pressure ventricular volume wall thickness
2. Heart rate3. Contractility
Determinants of Vascular Tone Relaxation of vascular smooth muscle by:1. Increase cGMP2. Decrease intracellular calcium3. Increase cAMP4. Stabilizing or preventing depolarization of
the vascular smooth muscle cell membrane
Treatment Plan: A. decrease the risk factor like
atherosclerosis, hypertension, smoking B. increase oxygen supply C. decrease oxygen demand
ANTIANGINAL DRUGS
I. AGENTS WHICH ↓ O2 DEMAND & ↑ O2 SUPPLY
A. NITRATES B. CALCIUM CHANNEL BLOCKERS
II. AGENTS WHICH ↓ O2 DEMAND C. BETA BLOCKERS
NITRATES AND NITRITESClassification of nitrates:1. Rapidly acting nitrates
* used to terminate acute attack of angina * e.g.- Nitroglycerin and Amyl nitrate * usually administered sublingually
2. Long acting nitrates * used to prevent an attack of angina * e.g. -Erythrytyl tetranitrate, Isosorbide
dinitrate, Pentaerythrytol tetranitrate * administered orally or topically
NitratesNitrates Coronary artery dilatation
Decrease coronary bed resistance (Relieved coronary vasospasm)
Increase coronary blood flow
Increase oxygen supply
NitratesNitrates
Reduction on peripheral resistance(Secondary to dilatation of aorta)
Decrease blood pressure
Decrease after load
Decrease workload
Decrease oxygen consumption
NitratesNitratesReduced venous return
(Due to dilatation of the veins)
Decrease left ventricular volume
Decrease preload
Decrease workload
Decrease oxygen consumption
EffectsEffects
1. Coronary artery dilatation2. Reduction of peripheral arterial
resistance – decrease after load3. Reduce venous return – decrease
preload
Potential Beneficial Effects of Nitrates. Beneficial effects Results
Decrease Ventricular vol. Decrease myocardial oxygen requirement
Decrease arterial pressure
Decrease ejection time
Venodilatation of epicardial coronary art.
Relief of coranary artery spasm
Increase collateral flow due to venodilatation
Increase perfusion to ischemic myocardium
Decrease left ventricular pressure > decrease preload due to dilatation of the vein > decrease after load due to dilatation of the arteries
Improved subendocardial perfusion
Deleterious Effects ResultsReflex tachycardia Increase myocardial
oxygen requirement
Reflex increase in contractility
Decrease diastolic perfusion
Decrease myocardial perfusion
Potential Deleterious EffectsPotential Deleterious Effects
ROUTES OF ADMINISTRATION
1. Sublingual route – rational and effective for the treatment of acute attacks of angina pectoris. Half-life depend only on the rate at which they are delivered to the liver.2. Oral route – to provide convenient and prolonged prophylaxis against attacks of angina3. Intravenous Route – useful in the treatment of coronary vasospasm and acute ischemic syndrome.4. Topical route – used to provide gradual absorption of the drug for prolonged prophylactic purpose.
Drug Usual single dose Route of administration
Duration of action
Short actingNitroglycerin
0.15-1.2 mg sublingual 10 - 30 min
Isosorbide dinitrate 2.5-5 mg sublingual 10 – 60 min
Amyl nitrite 0.18 – 3 ml inhalation 3 – 5 min
Long actingNitroglycerin sustained action
6.5 – 13 mg q 6-8 hrs oral 6 – 8 hrs
Nitroglycerin 2% ointment
1 – 1.5 inches q hr topical 3 – 6 hrs
Niroglycerin slow released
1 –2 mg per 4 hrs Buccal mucosa 3 – 6 hrs
Nitroglycerin slow released
10 – 25 mg /24hrs (one patch/day}
transdermal 8 –10 hrs
Isosorbide dinitrate 2.5 – 10 mg per 2 hrs sublingual 1.5 – 2 hrs
Isosorbide dinitrate 10 –60 mg per 4-6 hrs oral 4 – 6 hrs
Isosorbide dinitrate chewable
5 – 10 mg per 2-4 hrs oral 2 – 3 hrs
Isosorbide mononitrate 20 mg per 12 hrs oral 6 –10 hrs
Adverse EffectsAdverse Effects
1. Throbbing headache2. Flushing of the face3. Dizziness – especially at the beginning of
treatment4. Postural Hypotension – due to pooling of
blood in the dependent portion of the body
ContraindicationContraindication
1. Renal ischemia2. Acute myocardial infarction3. Patients receiving other
antihypertensive agent
B-BlockersB-Blockers
Hemodynamics Effects1. Decrease heart rate2. Reduced blood pressure and cardiac
contractility without appreciable decrease in cardiac output
B-BlockersB-Blockers
Decrease heart rate & Contractility
Increase duration of diastole Decrease workload Increase coronary blood flow Decrease O2 consumptionIncrease oxygen supply
ContraindicationContraindication
1. Congestive heart failure2. Asthma3. Complete heart block
Ca - Channel BlockersCa - Channel Blockers
Effects1. Coronary artery dilatation2. Reduction on peripheral arterial
resistance – decrease after load
Ca Channel BlockersCa Channel Blockers
Coronary artery dilatation
Decrease coronary bed resistance (Relieved coronary vasospasm)
Increase coronary blood flow
Increase oxygen supply
Ca channel BlockersCa channel BlockersReduction on peripheral resistance
(Secondary to dilatation of aorta)
Decrease blood pressure
Decrease after load
Decrease workload
Decrease oxygen consumption
Most commonly used Ca Channel Blockers1. Nifedipine2. Verafamil3. Diltiazem
Pharmacokineticss
Drugs Onset of action Peak of action Half-lifeNifedipine 20 minutes 1 hour 3-4 hours Verafamil 1-2 hours 5 hours 8-10 hoursDiltiazem 15 minutes 30 minutes 3-4 hours Nicardifine 20 minutes 45 minutes 2-4 hours Felodipine 2-5 hours 6-7 hours 11-16 hour
Unwanted effect Nausea and vomiting Dizzyness Flushing of the face Tachycardia – due to hypotension
Contraindications Cardiogenic shock Recent myocardial infarction Heart failure Atrio-ventricular block
Combination Theraphy1. Nitrates and B-blockers * The additive efficacy is primarily a result
of one drug blocking the adverse effect of the other agent on net myocardial oxygen consumption
* B-blockers – blocks the reflex tachycardia associated with nitrates
* Nitrates – attenuate the increase in the left ventricular end diastolic volume associated with B-lockers by increasing venous capacitance
2. Ca channel blockers and B-blockers * useful in the treatment of exertional
angina that is not controlled adequately with nitrates and B-blockers
* B-blockers – attenuate reflex tachycardia produce by nifedipine
* These two drugs produce decrease blood pressure
3. Ca channel blockers and Nitrates * Useful in severe vasospastic or
exertional angina (particularly in patient with exertional angina with congestive heart failure and sick sinus syndrome)
* Nitrates reduce preload and after load * Ca channels reduces the after load * Net effect is on reduction of oxygen
demand
4. Triple drugs – Nitrate + Ca channel blockers + B-blockers
*Useful in patients with exertional angina not controlled by the administration of two types of anti-anginal agent
* Nifidipine – decrease after load Nitrates – decrease preload B-blockers – decrease heart rate &
myocardial contractility
Type of Angina
Other Names Description Drug Therapy
STABLE ClassicExertionalFixedAtherosclerotic
Obstruction coronary artery
NitratesCCBB-blockers
VARIANT Prinzmetal’sVasospasmic
Vasospasm at any time
NitratesCCB
UNSTABLE Crescendo Combined effectPre= MI
Nitrates CCB